Advertisement Fidelity
Home > Boards > US OTC > Medical - Healthcare >

Itonis Inc. (ITNS)

ITNS RSS Feed
Add ITNS Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator slojab, sunspotter, smitter, 10bags, Pennystocktrader, rkrk
Search This Board:
Last Post: 4/16/2014 9:45:02 PM - Followers: 355 - Board type: Free - Posts Today: 0

                      

Itonis Holdings



 

OTC Pink Current Information

 

Market Value
$2,470,928  a/o Mar 05, 2014


Shares Outstanding
930,377,519 a/o Mar 19 2014

Float

154,828,864 a/o May 31, 2013
 

Authorized Shares
1,000,000,000  a/o Aug 31, 2013

http://itonisholdings.com/

and

http://paramountdiscoveries.com/

 

 

 

 

   
1. devision


ABOUT ITONIS PHARMACEUTICALS

Itonis pharmaceuticals was created as a new division of Itonis, Inc. in collaboration with world-famous Dr. Charles Hensley, the inventor of the Zicam® Cold Remedy. This innovative pharmaceutical organization will produce and market prescription homeopathic preparations and over-the-counter products to treat chronic diseases and common ailments. The company will select products based on the speed to market seeking to bypass where appropriate the traditional and lengthy FDA approval process, while still maintaining the strictest levels of both safety and efficacy.

Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. He was a founder of Geltech, LLC, the company that launched the Zicam® Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.



PIPELINE

 

In late August of 2012, Itonis pharmaceuticals introduced an over-the-counter, systemically active preparation delivered via a nasal and/or sublingual spray for the alleviation of mild to moderate nausea caused by motion sickness, dizziness, migraine, gastroenteritis, food poisoning, and possibly by chemotherapy, without many of the common side effects associated with current OTC and prescription treatments.

While the actual size of the market for nausea related drugs and preparations is difficult to estimate, it is suggested to be over half a billion dollars annually.
Itonis Pharmaceuticals plans to announce the details of upcoming human clinical studies for the nausea preparation formulation over the coming weeks as it files its provisional patents to protect its intellectual property.
 

http://itonisholdings.com/wp-content/uploads/2013/05/Emesyl2-4.jpg


MANAGEMENT TEAM

  • Charles Hensley, Ph.D

Charles Hensley, Ph.D., the inventor of Zicam® cold remedy is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic cocktails. In 1997, Dr. Hensley founded Geltech, LLC., the company that launched Zicam® and made the product a household name. With the launch of of Zicam® cold remedy, Dr. Hensley and co-workers changed the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley also developed Zicam® Allergy and the nasal delivery systems used in the Zicam® product line extensions. Dr. Hensley and his partners sold their stake in Geltech to Matrixx initiatives (MTXX).

In 2000, Dr. Hensley was president of Zengen, Inc., a bio-pharmaceutical company, and 2003 founded and served as Chairman and CEO of PRB Pharmaceuticals. He recently co-founded Universal Bio Innovations.

He received his B.S. from the University of Oklahoma and his Ph.D. in Physiology and Biophysics from the University of Southern California. He completed his post-doctoral fellowship in Molecular Cardiology at The University of Southern California in 1993. Subsequently he taught at The University of Southern California School of Pharmacy and medical students at the University of California, Riverside.

  • Mark Cheung

Mr. Cheung has more than 20 years of business law and entrepreneurial experience in the legal fields of business litigation and appeals. He has been a name partner at his Irvine, California law firm that has handled numerous business litigation and intellectual property matters, including a trademark case that ended favorably in the U.S. Supreme Court. Through years of litigation matters, Mr. Cheung has confronted unprecedented business operational disputes and relationship issues, providing industry opportunities to enhance and apply problem-solving skills at all levels.

Since 2001, Mr. Cheung has served on and chaired various not-for-profit boards for several organizations in Orange County, California. He chaired a consumer financial non-profit organization that included 20+ staff, over $2 million in assets and $1.7 million in annual revenues. He has chaired at a community college foundation with over $1.5 million in assets and endowments. Mr. Cheung has also served as a board member to several attorney bar associations, including the chair position for one such association.

Through his decade-long experience of serving and giving back to his community, Mr. Cheung found that such charitable organizations provided him first-hand experience with all aspects of the corporate and business world, including personnel, operations, financial, competition concerns, and reserve investing.

Since 2005, Mr. Cheung has also served as an adjunct professor, teaching upper-class levels at Chapman University School of Law.

Mr. Cheung received his Bachelor of Arts degree in Economics from Brandeis University, and his law degree from Boston College Law School. He has also published scholarly articles in the law.
 


2. devision

VERTEX

Paramount Discoveries









How Paramount Discoveries Became A Scientific Research Company


Paramount Discoveries, Inc. is a scientific research company originally founded in 1995 by Stuart Robbins. The company is the culmination of more than 16 years of dedicated research to develop a process that can stimulate magnetism in several common natural elements and minerals.
Paramount Discoveries' technologies use an arbitrary wave form generator combined with permanent magnets, and apply a rare frequency for each element or mineral to sustain its "magnetic moment", thus controlling the element or mineral.
The 16 years of research has helped Paramount Discoveries to successfully generate these unique frequencies and overcome the overwhelming scientific odds of finding the correct frequency. Now, Paramount Discoveries continues to challenge the scientific community, researching and developing new technologies that prove the astronomical odds of discovering these frequencies are still possible.

Technology / Working on:



 

 

 

Itonis Pharmaceuticals Received Emesyl Samples for Evaluation

Feb 28, 2014

OTC Disclosure & News Service

-

Itonis Pharmaceuticals Received Emesyl Samples for Evaluation

LAGUNA HILLS, CA--(Marketwired - Feb 28, 2014) - Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has received and is currently evaluating samples of its Emesyl™ product from its manufacturer. Oasis Health Products, Inc. delivered two versions of the Emesyl™ anti-nausea formula which are currently being evaluating for tolerance.

"The two versions differ in terms of preservative," says Ernesto Barron, Itonis' recently appointed Chief Scientific Officer. "We are looking at using a class of preservative that will not only maintain product stability but also will serve to sooth the nasal passages."

About Itonis Pharmaceuticals
Itonis Pharmaceuticals, a new division of Itonis, Inc., is headed by Charles Hensley, Ph.D. This division's mission is to create and market over-the-counter and prescription homeopathic products that better people's lives. Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. He was a founder of the company that launched the Zicam® Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.

About Itonis, Inc.
Itonis, Inc. was incorporated in the state of Nevada on July 5, 2005 under the name of Kenshou, Inc., which later changed to Itonis, Inc. on December 2, 2005. Please visit www.itonisholdings.com.

Safe Harbor:
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.

Contact:
Itonis, Inc.

 

Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy and Itonis Pharmaceuticals to Use Its Exclusive Manufacturer for Emesyl(TM) Anti-Nausea Swab and Oral Spray Products

LAGUNA HILLS, Calif., May 3, 2013 — Itonis, Inc. (ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that the Company’s exclusive manufacturer (Oasis Health Products, Inc.) will produce the Company’s anti-nausea swab and its oral spray products under the Emesyl(TM) brand.

The Company expects to commence the production process with Oasis Health Products for Emesyl(TM) in both the swab and oral spray forms.

Dr. Hensley said, “We are excited that we are working with Oasis to produce the first of our Emesyl(TM) anti-nausea products. We look forward to making Emesyl(TM) available to the general public to treat nausea ailments.”

About Itonis Pharmaceuticals

Itonis Pharmaceuticals, a new division of Itonis, Inc., is headed by Charles Hensley, Ph.D. This division’s mission is to create and market over-the-counter and prescription homeopathic products that better people’s lives. Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. He was a founder of the company that launched the Zicam(R) Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.

 

 

News News Alert: Itonis, Inc. Signed Exploratory Analysis Trial for Cloud9 Project With Valley Organics Inc. 04/16/2014 09:00:00 AM
PostSubject
#18274  Sticky Note Not science fiction ! Semperfifi 04/05/14 11:03:21 AM
#16957  Sticky Note Waiting For News on: surehands 03/29/14 03:50:07 PM
#13726  Sticky Note Good News: Emesyl Trademark Issue Review is complete profiteer11 03/11/14 05:45:02 AM
#13217  Sticky Note videocharting near big breakout we sit on 10bags 03/06/14 05:17:58 PM
#10804  Sticky Note "Shorts are trying so hard on this one." sunspotter 03/28/13 10:51:40 AM
#10662  Sticky Note From last night's ITNS lie-sheet: sunspotter 03/28/13 07:28:24 AM
#19376   Me 2 - The strong will prevail here.... surehands 04/16/14 09:45:02 PM
#19375   "Please don't confuse allopathic drugs like the original britguy2 04/16/14 09:10:47 PM
#19374   Same corporate description of Valley Organics given by DoughRay 04/16/14 07:29:45 PM
#19373   I think you are right. Lat* is bringing rugies 04/16/14 07:17:18 PM
#19372   LAT* needs a payment option for their myriad DoughRay 04/16/14 07:05:09 PM
#19371   With this all being said, it may be Mechanic71 04/16/14 07:02:52 PM
#19370   In the P/R it said Valley organics is Mechanic71 04/16/14 07:01:55 PM
#19369   Kool. ITNS is partnering with LAT*'s Valley Organics. Baaaaaaaaaaaaaaaaaaaaaaaa DoughRay 04/16/14 06:32:57 PM
#19368   Mechanic71.... From your mouth to ALL our wallets.. Gman24 04/16/14 06:25:32 PM
#19367   I'm predicting cavities will be forming Monday! vodkadejour 04/16/14 06:11:26 PM
#19366   I'm predicting big news Monday, combination of trademark Goberkir 04/16/14 06:06:59 PM
#19365   I think MYEC is insurance for Cloud9...Kind of Mechanic71 04/16/14 06:02:47 PM
#19364   "Well what do you know, according to the sunspotter 04/16/14 05:56:13 PM
#19363   Agree Mechanic71, the MM's will control this stock Gman24 04/16/14 05:48:50 PM
#19362   It's no wonder why MMs are tearing it Mechanic71 04/16/14 05:23:06 PM
#19361   It's no wonder why MMs are tearing it Mechanic71 04/16/14 05:22:48 PM
#19360   So we got MYEC, Cloud 9 (in 29 Mechanic71 04/16/14 05:21:35 PM
#19359   Yeppers! Patience will pay. Quietly adding when I smitter 04/16/14 04:10:34 PM
#19358   Emesyl around the corner...29 more days for Cloud9... Gman24 04/16/14 04:09:22 PM
#19357   Agree! Let's base and build from here! smitter 04/16/14 03:59:23 PM
#19356   It's about time to have a little rain kpisme 04/16/14 03:58:53 PM
#19355   Green Close I'll take it! Have a great evening smitter 04/16/14 03:57:32 PM
#19354   Come on girl.... Close for the HOD Gman24 04/16/14 03:44:17 PM
#19353   Historical Short Selling Data For ITNS vsop 04/16/14 03:40:44 PM
#19352   you have NO idea how many shares there hebroots 04/16/14 03:33:46 PM
#19351   Literally just need one big buyer and boom! smitter 04/16/14 03:28:40 PM
#19350   About 500k shares till .019 L_Rab 04/16/14 03:14:53 PM
#19349   Zicam 150 mill in revs a year! smitter 04/16/14 02:34:47 PM
#19348   This thing needs to RUN!!!!!!!!!!!!! pennystockpro32 04/16/14 02:30:13 PM
#19347   It hardly matters. As Emesyl is a homeopathic britguy2 04/16/14 02:22:56 PM
#19346   Rest assured, Emesyl is alive and well. Doesn't smitter 04/16/14 01:48:01 PM
#19344   just another slice of vague with jelly on top hebroots 04/16/14 01:33:27 PM
#19343   Yes with the bid going higher and higher...Begging Mechanic71 04/16/14 01:25:28 PM
#19342   This would require that they walk and chew hebroots 04/16/14 01:25:10 PM
#19341   Marketing concept makes me think it'd be in Mechanic71 04/16/14 01:24:31 PM
#19340   seeing red hebroots 04/16/14 01:21:57 PM
#19339   Very little volume today. They can take this Gman24 04/16/14 01:20:08 PM
#19338   WOW!! kkmke 04/16/14 01:06:09 PM
#19337   "Do you know what you own..its for nausea sunspotter 04/16/14 01:03:08 PM
#19336   Do you know what you own..its for nausea Fishercat 04/16/14 01:00:16 PM
#19335   Buyers want in..too bad, pay the price! Fishercat 04/16/14 12:58:24 PM
#19332   Yes Sir... Panic is over and Bottom should smitter 04/16/14 12:09:49 PM
#19331   Agree..... smitter 04/16/14 12:08:52 PM
#19330   Today's chart shows real strength. Pushing with volume. MrBlackLungs 04/16/14 12:08:12 PM
#19328   And even if the P/R is ready, (Let's Mechanic71 04/16/14 12:05:12 PM
#19327   Its gonna be big... Expecting Commercials and everything... smitter 04/16/14 12:02:50 PM
#19326   "With allergy season here...there is a new product Mechanic71 04/16/14 11:48:10 AM
#19325   Almost sounds like Emesyl news will come with Mechanic71 04/16/14 11:46:46 AM
#19324   YOU ROCK!!!! imo.... Me thinking Emesyl news coming smitter 04/16/14 11:27:55 AM
#19323   Just got an email in from the company profiteer11 04/16/14 11:24:11 AM
PostSubject